HeartSciences (HSCS) Change in Cash (2021 - 2026)
HeartSciences (HSCS) posted quarterly Change in Cash of -$1.7 million for Q2 2026, down 16.14% year-on-year from -$2.1 million in Q2 2025, and down 106.89% on a QoQ basis from -$841128.0 in Q4 2025.
HeartSciences (HSCS) Change in Cash (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Change in Cash for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.
- Quarterly Change in Cash fell 16.14% year-over-year to -$1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$2.4 million (up 49.34% YoY) and the FY2026 annual result came in at $558716.0, up 111.86% from the prior year.
- Change in Cash eased to -$1.7 million in Q2 2026 per HSCS's latest filing, from -$841128.0 in the prior quarter.
- Over the last five years, Change in Cash for HSCS reached as high as $7.0 million in Q1 2024 and fell as low as -$1.7 million in Q2 2026.
- A 5-year average of -$9382.2 and a median of -$841128.0 in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash sank 428.37% — and 2024, when it jumped 709.28%.
- Year by year, Change in Cash stood at -$1.2 million in 2022, then soared by 60.26% to -$475510.0 in 2023, then jumped by 39.51% to -$287658.0 in 2024, then slumped by 192.41% to -$841128.0 in 2025, then tumbled by 106.89% to -$1.7 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$1.7 million, -$841128.0, and $1.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | -1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.74 Mn |
| Oct 31, 2025 | -841,128.00 |
| Jul 31, 2025 | 1.69 Mn |
| Apr 30, 2025 | -1.50 Mn |
| Jan 31, 2025 | -1.46 Mn |
| Oct 31, 2024 | -287,658.00 |
| Jul 31, 2024 | -1.47 Mn |
| Apr 30, 2024 | -1.27 Mn |
| Jan 31, 2024 | 6.98 Mn |
| Oct 31, 2023 | -475,510.00 |
| Jul 31, 2023 | -1.08 Mn |
| Apr 30, 2023 | -270,485.00 |
| Jan 31, 2023 | -1.15 Mn |
| Oct 31, 2022 | -1.20 Mn |
| Jul 31, 2022 | 3.35 Mn |
| Apr 30, 2022 | -409,948.00 |
| Jan 31, 2022 | 957,829.00 |
| Oct 31, 2021 | 364,389.00 |
| Jul 31, 2021 | -717,491.00 |